Kalaris Therapeutics Inc (KLRS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kalaris Therapeutics Inc

    NASDAQ: KLRS · Real-Time Price · USD
    6.64
    -0.45 (-6.35%)
    At close: Oct 03, 2025, 3:59 PM
    6.77
    1.96%
    After-hours: Oct 03, 2025, 04:22 PM EDT

    Kalaris Therapeutics Inc Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022
    Period Ending Dec 31, 2023 Dec 31, 2022
    Revenue
    		 n/a n/a
    Cost of Revenue
    		 n/a n/a
    Gross Profit
    		 n/a n/a
    Operating Income
    		 -13.46M -14.01M
    Interest Income
    		 n/a n/a
    Pretax Income
    		 -14.7M -15.48M
    Net Income
    		 -14.7M -15.48M
    Selling & General & Admin
    		 1.76M 2.24M
    Research & Development
    		 11.71M 11.76M
    Other Expenses
    		 n/a n/a
    Operating Expenses
    		 13.46M 14.01M
    Interest Expense
    		 687K 235K
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 13.46M 14.01M
    Income Tax Expense
    		 n/a n/a
    Shares Outstanding (Basic)
    		 n/a n/a
    Shares Outstanding (Diluted)
    		 n/a n/a
    EPS (Basic)
    		 n/a n/a
    EPS (Diluted)
    		 n/a n/a
    EBITDA
    		 -14.01M -15.25M
    EBIT
    		 -14.01M -15.25M
    Depreciation & Amortization
    		 n/a n/a

    Add to Watchlist